2470 related articles for article (PubMed ID: 20919595)
21. Modeling costs and burden of informal caregiving for persons with bipolar disorder.
Wolff N; Perlick DA; Kaczynski R; Calabrese J; Nierenberg A; Miklowitz DJ
J Ment Health Policy Econ; 2006 Jun; 9(2):99-110. PubMed ID: 17007487
[TBL] [Abstract][Full Text] [Related]
22. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of integrated care for elderly depressed patients in the PRISM-E study.
Wiley-Exley E; Domino ME; Maxwell J; Levkoff SE
J Ment Health Policy Econ; 2009 Dec; 12(4):205-13. PubMed ID: 20195008
[TBL] [Abstract][Full Text] [Related]
24. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
Phanthunane P; Whiteford H; Vos T; Bertram M
J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
[TBL] [Abstract][Full Text] [Related]
25. Economic burden of rhinitis in managed care: a retrospective claims data analysis.
Dalal AA; Stanford R; Henry H; Borah B
Ann Allergy Asthma Immunol; 2008 Jul; 101(1):23-9. PubMed ID: 18681080
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of first suicide attempts in single versus multiple suicide attempters with bipolar disorder.
Michaelis BH; Goldberg JF; Singer TM; Garno JL; Ernst CL; Davis GP
Compr Psychiatry; 2003; 44(1):15-20. PubMed ID: 12524631
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population.
Davis KL; Candrilli SD; Edin HM
Epilepsia; 2008 Mar; 49(3):446-54. PubMed ID: 18031549
[TBL] [Abstract][Full Text] [Related]
28. Impact of leflunomide versus biologic agents on the costs of care for rheumatoid arthritis in a managed care population.
Ollendorf DA; Peterson AN; Doyle J; Huse DM
Am J Manag Care; 2002 May; 8(7 Suppl):S203-13. PubMed ID: 12022236
[TBL] [Abstract][Full Text] [Related]
29. Variation in patient routine costliness in U.S. psychiatric facilities.
Cromwell J; Drozd EM; Gage B; Maier J; Richter E; Goldman HH
J Ment Health Policy Econ; 2005 Mar; 8(1):15-28. PubMed ID: 15870482
[TBL] [Abstract][Full Text] [Related]
30. Treatment costs related to bipolar disorder and comorbid conditions among Medicaid patients with bipolar disorder.
Guo JJ; Keck PE; Li H; Patel NC
Psychiatr Serv; 2007 Aug; 58(8):1073-8. PubMed ID: 17664518
[TBL] [Abstract][Full Text] [Related]
31. Treatment costs and health care utilization for patients with bipolar disorder in a large managed care population.
Guo JJ; Keck PE; Li H; Jang R; Kelton CM
Value Health; 2008; 11(3):416-23. PubMed ID: 18179673
[TBL] [Abstract][Full Text] [Related]
32. Pursuing cost-effectiveness in mental health service delivery for youth with complex needs.
Grimes KE; Schulz MF; Cohen SA; Mullin BO; Lehar SE; Tien S
J Ment Health Policy Econ; 2011 Jun; 14(2):73-83. PubMed ID: 21881163
[TBL] [Abstract][Full Text] [Related]
33. Increased prevalence of psychiatric disorders and health care-associated costs among patients with moderate-to-severe psoriasis.
Han C; Lofland JH; Zhao N; Schenkel B
J Drugs Dermatol; 2011 Aug; 10(8):843-50. PubMed ID: 21818505
[TBL] [Abstract][Full Text] [Related]
34. The effects of expanded mental health benefits on treatment costs.
Sasso AT; Lurie IZ; Lee JU; Lindrooth RC
J Ment Health Policy Econ; 2006 Mar; 9(1):25-33. PubMed ID: 16733269
[TBL] [Abstract][Full Text] [Related]
35. [Suicide attempts by young adolescents: epidemiological characteristics of 517 15-year-old or younger adolescents admitted in French emergency departments].
Giraud P; Fortanier C; Fabre G; Ghariani J; Guillermain Y; Rouviere N; Chabrol B; Jouve JL; Simeoni MC
Arch Pediatr; 2013 Jun; 20(6):608-15. PubMed ID: 23628122
[TBL] [Abstract][Full Text] [Related]
36. The societal cost of schizophrenia in Sweden.
Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
[TBL] [Abstract][Full Text] [Related]
37. Cost and utilization outcomes of opioid-dependence treatments.
Baser O; Chalk M; Fiellin DA; Gastfriend DR
Am J Manag Care; 2011 Jun; 17 Suppl 8():S235-48. PubMed ID: 21761950
[TBL] [Abstract][Full Text] [Related]
38. Suicidal attempts in bipolar disorder: results from an observational study (EMBLEM).
Bellivier F; Yon L; Luquiens A; Azorin JM; Bertsch J; Gerard S; Reed C; Lukasiewicz M
Bipolar Disord; 2011 Jun; 13(4):377-86. PubMed ID: 21843277
[TBL] [Abstract][Full Text] [Related]
39. Trajectory analysis of healthcare costs for patients with major depressive disorder treated with high doses of duloxetine.
Cui Z; Faries DE; Zhao Y; Novick D; Liu X
J Med Econ; 2011; 14(5):662-72. PubMed ID: 21892857
[TBL] [Abstract][Full Text] [Related]
40. Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) study.
Hong J; Reed C; Novick D; Haro JM; Aguado J
Psychiatry Res; 2011 Nov; 190(1):110-4. PubMed ID: 21571375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
